Home
About
Services
Partners
Client Portfolio
News
Contact
S&P 500, Dow scale fresh three-month peaks
June 2, 2020
After Facebook staff walkout, Zuckerberg defends no action on Trump posts
June 2, 2020
0
Pfizer to invest up to $500 million in public drug developers
Published by
Muller&Green
at
June 2, 2020
Categories
RSS
Tags
Pfizer Inc said on Tuesday it will invest up to $500 million into publicly traded drug developers to fund their treatment candidates and provide access to the U.S. drugmaker’s scientific expertise.
Powered by
WPeMatico
Muller&Green
Related posts
June 18, 2020
Chanel warns virus impact will linger on luxury sector
Read more
June 18, 2020
IMF says deeper-than-expected contraction in U.S. economy likely in second quarter
Read more
June 18, 2020
Prudential sells Jackson equity stake to Apollo-backed Athene for $500 million
Read more